188 related articles for article (PubMed ID: 32186196)
1. Cisplatin nephrotoxicity is induced via poly(ADP-ribose) polymerase activation in adult zebrafish and mice.
Kim MJ; Moon D; Jung S; Lee J; Kim J
Am J Physiol Regul Integr Comp Physiol; 2020 May; 318(5):R843-R854. PubMed ID: 32186196
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity.
Kim J; Long KE; Tang K; Padanilam BJ
Kidney Int; 2012 Jul; 82(2):193-203. PubMed ID: 22437413
[TBL] [Abstract][Full Text] [Related]
3. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells.
Shino Y; Itoh Y; Kubota T; Yano T; Sendo T; Oishi R
Free Radic Biol Med; 2003 Oct; 35(8):966-77. PubMed ID: 14556861
[TBL] [Abstract][Full Text] [Related]
4. PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.
Yam-Canul P; Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):483-8. PubMed ID: 18331393
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase activation induces high mobility group box 1 release from proximal tubular cells during cisplatin nephrotoxicity.
Kim J
Physiol Res; 2016 Jun; 65(2):333-40. PubMed ID: 26447520
[TBL] [Abstract][Full Text] [Related]
6. Potential role of poly(ADP-ribose) polymerase (PARP) activation in methotrexate-induced nephrotoxicity and tubular apoptosis.
Dalaklioglu S; Sahin P; Ordueri EG; Celik-Ozenci C; Tasatargil A
Int J Toxicol; 2012; 31(5):430-40. PubMed ID: 22914891
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.
Mukhopadhyay P; Horváth B; Kechrid M; Tanchian G; Rajesh M; Naura AS; Boulares AH; Pacher P
Free Radic Biol Med; 2011 Nov; 51(9):1774-88. PubMed ID: 21884784
[TBL] [Abstract][Full Text] [Related]
8. 3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism.
Lakatos P; Szabó É; Hegedűs C; Haskó G; Gergely P; Bai P; Virág L
Biochim Biophys Acta; 2013 Mar; 1833(3):743-51. PubMed ID: 23246565
[TBL] [Abstract][Full Text] [Related]
9. NAM protects against cisplatin-induced acute kidney injury by suppressing the PARP1/p53 pathway.
Wu W; Fu Y; Liu Z; Shu S; Wang Y; Tang C; Cai J; Dong Z
Toxicol Appl Pharmacol; 2021 May; 418():115492. PubMed ID: 33722665
[TBL] [Abstract][Full Text] [Related]
10. PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.
Huang SH; Xiong M; Chen XP; Xiao ZY; Zhao YF; Huang ZY
Oncol Rep; 2008 Sep; 20(3):567-72. PubMed ID: 18695907
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury.
Mota RA; Sánchez-Bueno F; Saenz L; Hernández-Espinosa D; Jimeno J; Tornel PL; Martínez-Torrano A; Ramírez P; Parrilla P; Yélamos J
Lab Invest; 2005 Oct; 85(10):1250-62. PubMed ID: 16127429
[TBL] [Abstract][Full Text] [Related]
12. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
Dalaklioglu S; Tekcan M; Gungor NE; Celik-Ozenci C; Aksoy NH; Baykal A; Tasatargil A
Toxicol Lett; 2010 Feb; 192(2):91-6. PubMed ID: 19833176
[TBL] [Abstract][Full Text] [Related]
13. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
Tao X; Chen X; Hou Z; Hao S; Liu B
World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
[TBL] [Abstract][Full Text] [Related]
14. Roles of inhibitors of poly(ADP-ribose) polymerase in protecting rat RINm5F cell line against free fatty acid-induced apoptosis.
Mao X; Wang S; Pan Y; He B; Chen J; Jiang H; Zeng Q; Xu X
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):274-82. PubMed ID: 19513971
[TBL] [Abstract][Full Text] [Related]
15. Effect of poly(ADP-ribose) polymerase inhibition on outer medullary hypoxic damage.
Darmon D; Goldfarb M; Shina A; Rosen S; Heyman SN
Nephron Physiol; 2003; 95(1):p1-9. PubMed ID: 14520006
[TBL] [Abstract][Full Text] [Related]
16. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice.
Huang S; Zhang B; Chen Y; Liu H; Liu Y; Li X; Bao Z; Song Z; Wang Z
J Pharmacol Exp Ther; 2018 Mar; 364(3):452-461. PubMed ID: 29317476
[TBL] [Abstract][Full Text] [Related]
18. The effect of poly (ADP-ribose) polymerase inhibition on aminoglycoside-induced acute tubular necrosis in rats.
Biro A; Vaknine H; Cohen-Armon M; Matas Z; Fux A; Schreiber L; Berger E; Dan M; Boaz M; Gregoriev O; Katzir Z
Clin Nephrol; 2016 Apr; 85(4):226-34. PubMed ID: 26951968
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.
Szabó C; Biser A; Benko R; Böttinger E; Suszták K
Diabetes; 2006 Nov; 55(11):3004-12. PubMed ID: 17065336
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Poly(ADP-Ribose) Polymerase Increased Lipid Accumulation Through SREBP1 Modulation.
Pang J; Cui J; Xi C; Shen T; Gong H; Dou L; Lin Y; Zhang T
Cell Physiol Biochem; 2018; 49(2):645-652. PubMed ID: 30165350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
